2. 疾患モデリングル製品 Neuronal Signaling GPCR/G Protein Metabolic Enzyme/Protease
  3. Nervous System Disease Models Dopamine Receptor Endogenous Metabolite
  4. Parkinson's Disease Models
  5. L-DOPA

レボドパ  (Synonyms: L-DOPA; Levodopa)

製品番号: HY-N0304 純度: 99.98%
COA 取扱説明書 Technical Support

L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 59-92-7

容量 価格（税別） 在庫状況 数量
200 mg $60 在庫あり
1 g $84 在庫あり
5 g   お問い合わせ  
10 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 35 publication(s) in Google Scholar

Other Forms of L-DOPA:

レボドパ 関連抗体

Top Publications Citing Use of Products

顧客検証

WB
In Vivo Efficacy Study
IHC

    L-DOPA purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Apr 13:e2413376.  [Abstract]

    Behavior analysis of pole test, rotarod test, suspension test, and forced swimming test after administration of L-DOPA, NanoMassage or saline. Mice were given an oral administration of 20 mg/kg L-DOPA on 4th day of MPTP administration and sacrificed on the 8th day.

    L-DOPA purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Aug 19:e2403058.  [Abstract]

    Movement track and total distance travelled in the open field test, descent time in the pole test and time-to-fall in the rotarod test. Mice in the treatment groups intragastrically (i.g.) administered 20 mg/kg/d L-DOPA for 27 days.

    L-DOPA purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Aug 19:e2403058.  [Abstract]

    Immunohistochemical staining of TH+ neurons. Mice in the treatment groups intragastrically (i.g.) administered 20 mg/kg/d L-DOPA for 27 days.

    L-DOPA purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Aug 19:e2403058.  [Abstract]

    Quantification of TH+ neurons. Mice in the treatment groups intragastrically (i.g.) administered 20 mg/kg/d L-DOPA for 27 days.

    L-DOPA purchased from MedChemExpress. Usage Cited in: CNS Neurosci Ther. 2023 Oct;29(10):2925-2939.  [Abstract]

    Amphiregulin (Areg) is highly expressed in the levodopa‐induced dyskinesia 6‐OHDA (4 μg; 4 weeks) Parkinson's disease mouse model. The Parkinson's disease group treated with a daily 12 mg/kg of levodopa for 15 days developed dyskinetic movement. On western blotting, this group further showed a significant increase of Amphiregulin protein expression relative to the Parkinson's disease group injected with normal saline only .

    Dopamine Receptor アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    Dopamine Receptor D1 Receptor D2 Receptor D3 Receptor D4 Receptor D5 Receptor

    Endogenous Metabolite アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    Human Endogenous Metabolite Microbial Metabolite

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease[1][2][3].

    IC50 & Target

    Human Endogenous Metabolite

     

    Cellular Effect
    Cell Line Type Value Description References
    CHO IC50
    141200 μM
    Compound: L-dopa
    TP_TRANSPORTER: inhibition of Gly-Sar uptake (Gly-Sar: 20 uM) in PEPT1-expressing CHO cells
    TP_TRANSPORTER: inhibition of Gly-Sar uptake (Gly-Sar: 20 uM) in PEPT1-expressing CHO cells
    		[PMID: 10052994]
    体内実験

    Note:
    Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.

    L-DOPA can be used to create movement disorder models. In adult common marmosets, after oral administration of L-DOPA (20 mg/kg, 5 mg/kg), the Tmax in plasma is 30 minutes, and the Tmax in striatal extracellular fluid (ECF) is 60-90 minutes. The mean Cmax of L-DOPA in plasma is 20.3 μM, while the mean Cmax in striatal ECF is 442.9 nM, representing about 2.2% of the plasma level[6].

    Induction of dyskinesia model[5]
    Background
    L-DOPA-induced dyskinesia results from a pulsatile stimulation of brain dopamine (DA) receptors, triggering a complex cascade of molecular and synaptic alterations within the basal ganglia[5].
    Specific Modeling Methods
    Mice: C57Bl/6 mice • male • 8 weeks (period: 21 days)
    Administration: 20 mg/kg • ip • once daily for 21 days
    Note
    (1) sustained unilateral 6-OHDA injections in the striatum before starting treatment.
    (2) Injection volume is 10mL/kg body weight.
    Modeling Indicators
    Behavioral changes: Shows developed abnormal involuntary movements (AIMs) affecting the head, trunk and forelimb on the side contralateral to the lesion.
    Correlated Product(s): Oxidopamine hydrochloride (HY-B1081)
    Opposite Product(s): Oxidopamine hydrobromide (HY-B1081A)

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: 7-week-old C57BL/6J mice[3]
    Dosage: 20 mg/kg
    Administration: Orally
    Result: Reduced Rotenone-induced motor dysfunction.
    Animal Model: Sprague-Dawley rats (male 100-150 g)[4]
    Dosage: 10, 30, 50, 70, and 100 mg/kg
    Administration: Orally
    Result: Reverses tactile, cold and heat allodynia in neuropathic rat without any side effect.
    分子量

    197.19

    分子式

    C9H11NO4
    CAS 番号
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    N[C@@H](CC1=CC(O)=C(C=C1)O)C(O)=O
    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.
    保管条件

    4°C, stored under nitrogen

    *The compound is unstable in solutions, freshly prepared is recommended.
    溶剤 & 溶解度
    体外: 

    0.1 M HCl : 20 mg/mL (101.43 mM; ultrasonic and warming and adjust pH to 2 with HCl and heat to 60°C)

    DMSO : 2 mg/mL (10.14 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : 1 mg/mL (5.07 mM; Need ultrasonic)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 5.0713 mL 25.3563 mL 50.7125 mL
    5 mM 1.0143 mL 5.0713 mL 10.1425 mL
    10 mM 0.5071 mL 2.5356 mL 5.0713 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始）

    C1

    ×
    体積 （開始）

    V1

    =
    濃度 （終了）

    C2

    ×
    体積 （終了）

    V2

    体内:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  PBS

      Solubility: 3.33 mg/mL (16.89 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    純度とドキュメンテーション

    純度: 99.98%

    COA (246 KB) RP-HPLC (230 KB)

    取扱説明書 (2659 KB)
    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O / DMSO / 0.1 M HCl 1 mM 5.0713 mL 25.3563 mL 50.7125 mL 126.7813 mL
    5 mM 1.0143 mL 5.0713 mL 10.1425 mL 25.3563 mL
    DMSO / 0.1 M HCl 10 mM 0.5071 mL 2.5356 mL 5.0713 mL 12.6781 mL
    0.1 M HCl 15 mM 0.3381 mL 1.6904 mL 3.3808 mL 8.4521 mL
    20 mM 0.2536 mL 1.2678 mL 2.5356 mL 6.3391 mL
    25 mM 0.2029 mL 1.0143 mL 2.0285 mL 5.0713 mL
    30 mM 0.1690 mL 0.8452 mL 1.6904 mL 4.2260 mL
    40 mM 0.1268 mL 0.6339 mL 1.2678 mL 3.1695 mL
    50 mM 0.1014 mL 0.5071 mL 1.0143 mL 2.5356 mL
    60 mM 0.0845 mL 0.4226 mL 0.8452 mL 2.1130 mL
    80 mM 0.0634 mL 0.3170 mL 0.6339 mL 1.5848 mL
    100 mM 0.0507 mL 0.2536 mL 0.5071 mL 1.2678 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    L-DOPA Related Classifications

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    L-DOPA59-92-7Levodopa 3,4-DihydroxyphenylalanineDopamine ReceptorEndogenous MetaboliteOrallyprecursorneurotransmittersdopamineblood-brainbarrieranti-allodynicParkinsonInhibitorinhibitorinhibit

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

    		  

    カスタマ需要量 *

    お名前 *

    		 

    タイトル

    メールアドレス *

    		 

    電話番号 *

    デパートメント

    		 

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

    		      

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    L-DOPA
    製品番号:
    HY-N0304
    数量:
    MCE 日本正規代理店:

    カスタマーレビュー

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    製品名

    		  

    Lot #

    お名前 *

    		 

    メールアドレス *

    電話番号 *

    		 

    部門 *

    組纖名 *

    		 

    国或いは地域 *

    備考

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.